Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Cadila Healthcare board to consider unaudited financial results

>>

Zydus Cadila receives USFDA nod for Irbesartan Tablets

>>

Cadila Healthcare’s subsidiary receives USFDA’s nod for generic pain reliever Ultracet

>>

Cadila Healthcare finalizes definitive agreement with Microbix

>>

Cadila Healthcare’s Q1 consolidated net declines 15%

>>

Cadila Healthcare shines on getting USFDA’s nod for Aripiprazole Orally Disintegrating Tablets

>>

Zydus Cadila receive USFDA’s tentative approval for Aripiprazole Orally Disintegrating Tablets

>>

Cadila Healthcare gains on inking settlement and license pact with Somaxon

>>

Cadila Healthcare inks settlement and license pact with Somaxon

>>

Cadila Healthcare spurts as USFDA approves its Moraiya facilities

<< < 165 166 167 ...168 > >>